Primary Immunodeficiency Clinical Trial Patient Recruitment

Primary immunodeficiency patient recruitment for IVIG, gene therapy, and HSCT clinical trials.

Who qualifies: Patients with confirmed PID including CVID, XLA, SCID, and other antibody deficiencies.

Recruitment challenges: Immunoglobulin level and lymphocyte subset requirements.

Our approach: Allergy/immunology and hematology referral networks with immunoglobulin pre-screening.